Cargando…
Micronized purified flavonoid fraction for the treatment of chronic venous insufficiency, with a focus on postthrombotic syndrome: A narrative review
INTRODUCTION: Postthrombotic syndrome (PTS) is a form of secondary chronic venous insufficiency (CVI) that occurs after deep vein thrombosis (DVT). Effective treatments for PTS are lacking. Micronized purified flavonoid fraction (MPFF) is a venoactive drug used in the treatment of CVI. OBJECTIVE: To...
Autores principales: | Li, Ke Xuan, Diendéré, Gisele, Galanaud, Jean‐Philippe, Mahjoub, Nada, Kahn, Susan R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8128666/ https://www.ncbi.nlm.nih.gov/pubmed/34027293 http://dx.doi.org/10.1002/rth2.12527 |
Ejemplares similares
-
MUFFIN-PTS trial, Micronized Purified Flavonoid Fraction for the Treatment of Post-Thrombotic Syndrome: protocol of a randomised controlled trial
por: Galanaud, Jean Philippe, et al.
Publicado: (2021) -
The Benefits of Micronized Purified Flavonoid Fraction (MPFF) Throughout the Progression of Chronic Venous Disease
por: Nicolaides, Andrew N.
Publicado: (2020) -
Treatment of haemorrhoidal disease with micronized purified flavonoid fraction and sucralfate ointment
por: Amaturo, Antonino, et al.
Publicado: (2020) -
Micronized Purified Flavonoid Fraction (MPFF) for Patients Suffering from Chronic Venous Disease: A Review of New Evidence
por: Ulloa, Jorge H.
Publicado: (2019) -
Micronized Purified Flavonoid Fraction in Hemorrhoid Disease: A Systematic Review and Meta-Analysis
por: Sheikh, Parvez, et al.
Publicado: (2020)